Business impact target: non-qualifying regulatory proposals: 21 June 2019 - 12 December 2019
Updated 20 December 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/the-business-impact-target/business-impact-target-non-qualifying-regulatory-proposals-21-june-2019-12-december-2019
| Excluded category* | Summary of measure(s), including any impact data where available** |
|---|---|
| Measures certified as being below de minimis (measures with an EANDCB below +/- £5 million) | Since 21 June, through to present, IPO engaged with 1303 businesses and business advisors regarding Intellectual Property (IP), through attending or running 25 events including seminars, workshops, webinars or business exhibitions. IPO also delivered intensive 3-day IP training to 29 businesses or business advisors during this period and facilitated IP audits for 195 businesses. In addition to this, our network of Patent Libraries have provided advice to 4,317. IPO updated the following guidance: Manual of Patent Practice to provide guidance on any relevant case law over the period. IPO dealt with the following number of applications between 21 June and 30 November: Patent Applications: 8561. Trade Mark Applications: 39,644. Designs Applications: 12,236. |
| EU Regulations, Decisions and Directives and other international obligations, including the implementation of the EU Withdrawal Bill and EU Withdrawal Agreement | Regulation (EU) 2019/933 of the European Parliament and of the Council of 20 May 2019 amending Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products. Came into force 1 July 2019. The Regulation relates to supplementary protection certificates (SPCs), which provide an additional period of protection for a medicine after expiry of the patent protecting it. The Regulation provides a manufacturing waiver, under which SPC-protected medicines can be made for export outside the EU, or for storage ready for sale in the EU after the SPC expires. |
| Measures certified as concerning EU Withdrawal Bill operability measures. | |
| Pro-competition. | |
| Systemic Financial Risk. | |
| Civil Emergencies. | |
| Fines and Penalties. | |
| Misuse of Drugs. | |
| Measures certified as relating to the safety of tenants, residents and occupants in response to the Grenfell tragedy. | |
| Casework. | |
| Education, communications and promotion. | |
| Activity related to policy development. | |
| Changes to management of regulator. |
*For detailed guidance on the exclusion categories, please see Better regulation framework.
**Complete the summary box as ‘Following consideration of the exclusion category there are no measures for the reporting period that qualify for the exclusion.’ where this is appropriate.